2018 ACR/ARHP Invited Speaker and Moderator Disclosures

60 Pages·2017·0.76 MB·English

by  Sara Keene

2018 ACR/ARHP Invited Speaker and Moderator Disclosures
The following types of relationships may be deemed relevant include:
1. Stocks, stock options, or bond holdings in a for-profit corporation or self-directed pension plan
2. Research grants
3. Employment (full or part-time)
4. Ownership or partnership
5. Consulting fees or other remuneration (payment)
6. Non-remunerative positions of influence such as officer, board member, trustee or public spokesperson
7. Receipt of royalties
8. Speakers bureau
9. Other
A Agarwal, Vikas, MD, DM
4M113 ACR: Immunizations & Infections
Abelson, Abby, MD Potpourri
4M028 ACR: Paul Klemperer, MD Memorial Disclosure: Nothing to Disclose
Lecture: Destructive Arthritis: From
Progression to Remission & Prevention Aggarwal, Amit, PhD
Disclosure: Nothing to Disclose 3S048 ACR: Knowledge Bowl Preliminary
Round
5T081 ACR: ACR Business Meeting Disclosure: Nothing to Disclose
Disclosure: Nothing to Disclose
4M038 ACR: Knowledge Bowl Final Round
Abramowicz, Shelly, DMD, MPH, FACS Disclosure: Nothing to Disclose
5T040 ACR: JIA-Associated TMJ Arthritis:
New Guidelines for Evaluation, Scoring & Aizer, Juliet, MD, MPH
Management 5T052 ACR: 2018 CARE: MOC Session 3 of 3:
Disclosure: Nothing to Disclose OA & Gout/Pseudogout
Disclosure: Nothing to Disclose
Abularrage, Christopher, MD
5T048 ACR: Anatomy in a Day: Supra-Aortic Al Snih, Soham, MD, PhD
Vasculature Anatomy, Physiology & 5T027 ACR/ARHP: Answering Clinically
Pathoanatomy Relevant Questions Using Large Datasets
Disclosure: Medtronic, 5 Disclosure: Nothing to Disclose
Adelowo, Olufemi, MD, FRCP, MACR Al-awqati, Mina, MD
4M019 ACR: AFLAR: Out of Africa: Of 3S048 ACR: Knowledge Bowl Preliminary
Rheumatic Diseases: Pattern, Genetics & Round
Advocacy Disclosure: Nothing to Disclose
Disclosure: Nothing to Disclose
4M038 ACR: Knowledge Bowl Final Round
Disclosure: Nothing to Disclose
2018 Invited Speaker and Moderator Disclosures 1
Alarcón-Riquelme, Marta, MD, PhD Amodeo, Kayla, PhD
2S005 Pre-Mtg: ACR BRC: Epigenetics in 3S021 ACR: Sustain Your Practice: 2018
Immune-Mediated Disease: Day 2 of 2 Medicare Update on MACRA & APMs
Disclosure: Nothing to Disclose Disclosure: Nothing to Disclose
Albayda, Jemima, MD, RhMSUS Angeles-Han, Sheila, MD, MSc
4M018 Workshop: 214 - Joint Injections 3S034 ACR: Pediatric Uveitis in the Biologic
(Knee, Ankle, Shoulder & Wrist) Age: Risk Factors, Treatment & Outcomes
Disclosure: Nothing to Disclose Disclosure: Nothing to Disclose
5T020 Workshop: 225 - Joint Injections Anolik, Jennifer, MD, PhD
(Knee, Ankle, Shoulder & Wrist) 3S058 ACR: Immunology Update - Next
Disclosure: Nothing to Disclose Generation of B Cell and Plasma Cell
Therapies
Albert, Daniel, MD Disclosure: Nothing to Disclose
3S095 ACR/ARHP: Psychiatry for the
Rheumatology Practice Ansell, David, MD, MPH
Disclosure: Nothing to Disclose 5T021 ACR: Ethical Issues in Clinical
Practice: Providing the Best Care & System
3S017 ACR: RA: Beyond Treat to Target Challenges
Disclosure: AbbVie, Merck, UCB, Janssen, Disclosure: Nothing to Disclose
BMS, Pfizer, Medac, Roche, Lilly, MSD,
Janssen, 5, 8; MSD, BMS, Abbvie, 2 Antiochos, Brendan, MD
3S023 ACR: Orbital Invaders: Differential
Allen, Kelli, PhD Diagnosis & Management of Orbital Mass
3S062 ACR/ARHP: Randomized Trials for Lesions
Clinical Researchers 101: Design & Analysis Disclosure: Nothing to Disclose
Overview
Disclosure: Nothing to Disclose Appel, Gerald
2S002 Pre-Mtg: ACR Review Course
3S094 ACR/ARHP: Interdisciplinary Disclosure: Achillion, Omeros, Genentech,
Management of Chronic Musculoskeletal Sanofi-Genzyme, Alnylam, BMSqibb,
Pain in Older Adults Regulus, Merck , EMD Serono, Pfizer,
Disclosure: Nothing to Disclose Alexion,, 5; regulus , BMSquibb, EMD
Serono, Acillion,, 2; Sanofi-Genzyme,
Alvarez, Carolina, MS Genentech, 8; Up-To -Date, 7
3S116 ACR/ARHP: Innovative Statistics:
Joint Modeling of Time-to-Event &
Longitudinal Data
Disclosure: Nothing to Disclose

2018 Invited Speaker and Moderator Disclosures 2
Appleton, Tom, MD, PhD Disclosure: Bayer, 2; Biogen Idec, 2;
3S033 ACR: Novel Inflammatory Pathways Boehringer Ingelheim, 2, 5; Momenta, 2
in OA
Disclosure: Academic Medical Organization B
of Southwestern Ontario, 2; Amgen, 5;
Pfizer, 5; The Arthritis Society, 2 Baer, Alan N., MD
3S043 ACR: Sjogren’s Syndrome: Beyond
4M095 ACR/ARHP: Post-Traumatic OA: Dryness: A Comprehensive Approach to
Pathogenesis, Clinical Evolution & Diagnosis and Management
Management Disclosure: Nothing to Disclose
Disclosure: Academic Medical Organization
of Southwestern Ontario, 2; Amgen, 5; Bahr, Janet, NP
Pfizer, 5; The Arthritis Society, 2 5T117 ACR/ARHP: Bring It Home: Utilizing
Telemedicine for the Health Care
Arbeeva, Liubov, MS Professional
3S116 ACR/ARHP: Innovative Statistics: Disclosure: Nothing to Disclose
Joint Modeling of Time-to-Event &
Longitudinal Data Baker, Nancy A., ScD, MPH, OTR/L, FAOTA
Disclosure: Nothing to Disclose 4M031 ARHP: Utilizing PROMIS® for
Research & Clinical Care
Ardoin, Stacy P., MD, MS Disclosure: Nothing to Disclose
3S014 Workshop: 202 - Working with
Millennials in Your Practice: Skills, Tools, 5T008 ARHP: The Placebo Effect in
and Pearls Rheumatology
Disclosure: Nothing to Disclose Disclosure: Nothing to Disclose

3S122 MTP: 021 - Pediatric SLE 5T027 ACR/ARHP: Answering Clinically
Disclosure: Nothing to Disclose Relevant Questions Using Large Datasets
Disclosure: Nothing to Disclose
Arkin, Lisa, MD
6W015 ACR/ARHP: Dermatology Update: 5T117 ACR/ARHP: Bring It Home: Utilizing
New Findings on Rheumatic Skin Disease Telemedicine for the Health Care
Across the Lifespan Professional
Disclosure: Nothing to Disclose Disclosure: Nothing to Disclose
Ascherman, Dana P., MD
3S112 ACR: Autoimmune Pathogenesis &
the Lung
Disclosure: Nothing to Disclose

Assassi, Shervin, MD, MS
5T046 ACR Abstract: Plenary Session III
(2785–2790)
2018 Invited Speaker and Moderator Disclosures 3
Bakewell, Catherine, MD, RhMSUS Barbour, Kamil E., PhD, MPH, MS
1F001 Pre-Mtg: ACR Musculoskeletal 5T027 ACR/ARHP: Answering Clinically
Ultrasound Course for Rheumatologists - Relevant Questions Using Large Datasets
Day 1 of 2 Disclosure: Nothing to Disclose
Disclosure: AbbVie Inc., 5, 8; Novartis
pharmaceutical company, 5; Regeneron, 8 Bardin, Thomas
5T023 ACR: Crystals Symposium: Urate &
2S001 Pre-Mtg: ACR Musculoskeletal Beyond
Ultrasound Course for Rheumatologists - Disclosure: Nothing to Disclose
Day 2 of 2
Disclosure: AbbVie Inc., 5, 8; Novartis Bari, Mohammed, MD
pharmaceutical company, 5; Regeneron, 8 3S048 ACR: Knowledge Bowl Preliminary
Round
2S006 Pre-Mtg: ACR Musculoskeletal Disclosure: Nothing to Disclose
Ultrasound Course for Rheumatologists -
Advanced 4M038 ACR: Knowledge Bowl Final Round
Disclosure: AbbVie Inc., 5, 8; Novartis Disclosure: Nothing to Disclose
pharmaceutical company, 5; Regeneron, 8
Barker, Andrea, MPAS, PA-C
3S031 Workshop: 204 - Advanced MSUS: 4M098 Workshop: 220 - Shoulder Pain:
Image Optimization & Pathology Clinical & Ultrasound Assessment
Recognition Disclosure: Nothing to Disclose
Disclosure: AbbVie Inc., 5, 8; Novartis
pharmaceutical company, 5; Regeneron, 8 Basharat, Pari, MD, FRCPC
4M018 Workshop: 214 - Joint Injections
4M036 Workshop: 215 - Advanced MSUS: (Knee, Ankle, Shoulder & Wrist)
Image Optimization & Pathology Disclosure: AbbVie Inc., 5; Amgen Inc., 1, 5;
Recognition Janssen, 5; Pfizer, Inc., 5; Roche, 5
Disclosure: AbbVie Inc., 5, 8; Novartis
5T020 Workshop: 225 - Joint Injections
pharmaceutical company, 5; Regeneron, 8
(Knee, Ankle, Shoulder & Wrist)

Disclosure: AbbVie Inc., 5; Amgen Inc., 1, 5;
5T048 ACR: Anatomy in a Day: Supra-Aortic
Janssen, 5; Pfizer, Inc., 5; Roche, 5
Vasculature Anatomy, Physiology &
Pathoanatomy
Bass, Anne R., MD
Disclosure: AbbVie Inc., 5, 8; Novartis
2S007 Pre-Mtg: ACR/ARHP Immunology
pharmaceutical company, 5; Regeneron, 8
Breakthroughs: Impact on Diagnosis and
Therapy
Ballestar, Esteban, PhD
Disclosure: Nothing to Disclose
1F003 Pre-Mtg: ACR BRC: Epigenetics in
Immune-Mediated Disease: Day 1 of 2
4M057 ACR: Medical Education Year in
Disclosure: Nothing to Disclose
Review
Disclosure: Nothing to Disclose

2018 Invited Speaker and Moderator Disclosures 4
Basu, Neil, MD PhD Benham, Heather, DNP, RN, CPNP
5T097 ACR/ARHP: Fibromyalgia in RA, 3S117 ACR/ARHP: Practical Use of
Spondyloarthritis or Sjögren’s Syndrome Advanced Practice Providers in
Patients Rheumatology
Disclosure: Eli Lilly and Co., 5; Pfizer, Inc., 2 Disclosure: Nothing to Disclose
Bathon, Joan, MD Benseler, Susanne, MD PhD
4M030 ACR/ARHP: Pump Up Your 5T011 MTP: 055 - Brain on Fire: Update on
Presentation: Graphics, Tables & Talks Inflammatory Brain Diseases
Disclosure: Regeneron, 5 Disclosure: Nothing to Disclose
Battafarano, Daniel F., DO Berianu, Florentina, MD
6W028 ARHP: Disaster Preparedness in 3S048 ACR: Knowledge Bowl Preliminary
Rheumatology: Are You Ready? Round
Disclosure: Nothing to Disclose Disclosure: Nothing to Disclose
Batterman, Adena, LCSW, MS 4M038 ACR: Knowledge Bowl Final Round
4M004 ARHP: Daltroy Memorial Lecture: Disclosure: Nothing to Disclose
What Matters in Patient-Provider
Relationships? Values, Attitudes & Beliefs Bermas, Bonnie L., MD
Disclosure: Nothing to Disclose 5T096 ACR: Reproductive Health in
Rheumatology Patients: New ACR Clinical
Battistone, Michael J., MD Guideline
4M098 Workshop: 220 - Shoulder Pain: Disclosure: UptoDate, 7
Clinical & Ultrasound Assessment
Disclosure: ABIM Rheumatology Exam Berney, Seth, MD
Committee, 9 4M092 ACR: Osteoporosis: Bone-Breaking
News
Beach, Carrie, BSN, RN-BC Disclosure: Nothing to Disclose
5T028 ARHP: Rheumatology 101
Disclosure: Nothing to Disclose 4M110 ACR: Thieves' Market: Show Me
Your Best Cases
Beard, Madeline, BSN Disclosure: Nothing to Disclose
5T097 ACR/ARHP: Fibromyalgia in RA,
Spondyloarthritis or Sjögren’s Syndrome 5T051 ACR: Leadership Skills for the 21st
Patients Century Rheumatologist: Extend Your
Disclosure: Nothing to Disclose Sphere of Influence
Disclosure: Nothing to Disclose
Ben-Artzi, Ami, M.D.
4M098 Workshop: 220 - Shoulder Pain: Beukelman, Timothy, MD, MSCE
Clinical & Ultrasound Assessment 3S016 ACR: Biologic Classification of JIA
Disclosure: Nothing to Disclose Disclosure: Bristol-Myers Squibb, 5;
Novartis, 5; Sobi, 5; UCB, Inc., 5
2018 Invited Speaker and Moderator Disclosures 5
Bhana, Suleman, MD Blakely, Kent, MD
4M062 ACR: Tech Tools for Rheumatology: 4M026 ACR: Using Clinical Data to Drive
Version 3.0 Impactful Payer-Provider Collaboration
Disclosure: Nothing to Disclose Disclosure: **Missing Disclosure**
Biehl, Ann, PharmD Blanco, Irene, MD, MS
4M115 ACR/ARHP: Integrating Pharmacists 5T006 ARHP: Collaborative Initiatives
Into the Workforce (COIN): A Rheumatology Resource Toolbox
Disclosure: Nothing to Disclose Disclosure: Nothing to Disclose
5T034 ARHP: Red Herring: Medication Side Blaser, Martin, MD
Effect or Rheumatology Symptom? 3S022 ACR: Missing Microbes: Lost From
Disclosure: Nothing to Disclose Our Clinics
Disclosure: Nothing to Disclose
Bijlsma, Johannes W. J., Prof, PhD, MD
3S091 ACR: EULAR: Back to the Future: Blitz, Jill R., PT, DPT
Transformative Vision for RA? 3S096 ARHP: JIA Action Steps: Occupational
Disclosure: Nothing to Disclose and Physical Therapy Referrals
Disclosure: Nothing to Disclose
5T083 ACR: ILAR: Innovative Patient
Education to Overcome Patient Barriers Block, Joel A., MD
Disclosure: Nothing to Disclose 4M011 MTP: 032 - OA Management
Without Surgery in 2018
Bingham III, Clifton O., MD Disclosure: Agios, Inc, 7; Daiichi Sankyo, Inc.,
1F004 Pre-Mtg: ACR CRC – Applications of 7; Gilead, 1; GlaxoSmithKline, 5; Janssen, 2;
Mobile Health Technologies: Day 1 of 2 Novartis, 2; Omeros, Inc., 7; Pfizer, Inc., 2;
Disclosure: AbbVie Inc., 5; BMS, 2; Janssen, Zynerba Pharmaceuticals, 5
5; Lilly, 5; Pfizer, Inc., 5
4M116 ACR/ARHP: OA Management: Non-
Binstadt, Bryce A., MD, PhD Pharmacologic, Pharmacologic &
4M093 ACR: Rheumatology Research Controversial Approaches
Foundation: Arthritis Research Showcase Disclosure: Agios, Inc, 7; Daiichi Sankyo, Inc.,
Disclosure: Nothing to Disclose 7; Gilead, 1; GlaxoSmithKline, 5; Janssen, 2;
Novartis, 2; Omeros, Inc., 7; Pfizer, Inc., 2;
Bird, Paul, MD, PhD, GDMRI Zynerba Pharmaceuticals, 5
1F004 Pre-Mtg: ACR CRC – Applications of
Mobile Health Technologies: Day 1 of 2 Boackle, Susan A., MD
Disclosure: Nothing to Disclose 3S046 ACR: The Aging Immune Cell &
Autoimmunity
Birnbaum, Julius, MD, MHS Disclosure: Nothing to Disclose
2S002 Pre-Mtg: ACR Review Course
Disclosure: Nothing to Disclose
2018 Invited Speaker and Moderator Disclosures 6
Boers, Maarten, Prof. Dr. Bruce, Susan, PharmD
4M030 ACR/ARHP: Pump Up Your 4M024 ARHP: Interdisciplinary Case
Presentation: Graphics, Tables & Talks Presentation: An SLE Patient from Pediatrics
Disclosure: Epiconsult BV, 4 to Adult
Disclosure: Nothing to Disclose
Boin, Francesco, MD
5T055 MTP: 062 - Scleroderma Mimics Bruyn, George A. W., MD, PhD
Disclosure: Nothing to Disclose 4M119 MTP: 046 - 50 Ways to Treat Your
Patient With Complicated Gout
Bookman, Arthur, FRCPC Disclosure: Nothing to Disclose
3S043 ACR: Sjogren’s Syndrome: Beyond
Dryness: A Comprehensive Approach to 5T080 Workshop: 227 - Ultrasonography in
Diagnosis and Management Salivary Gland Disease
Disclosure: Nothing to Disclose Disclosure: Nothing to Disclose
Borenstein, David G., MD Bucala, Richard J., MD, PhD
3S012 MTP: 009 - Pain: Evaluation & 5T047 ACR: Publishing in Rheumatology
Treatment of Back Pain Journals: Hands-On Tips From the
Disclosure: Pfizer, Inc., 5; Regeneraon, 5 A&R/AC&R Editors
Disclosure: Nothing to Disclose
Bottini, Nunzio, MD, PhD
4M006 ACR: Immunology Update - Bunyard, Matthew, MD
Mechanisms & Effects of Selective JAK 4M001 ACR: CPC: Under the Microscope:
Inhibitors The Evolution of a Diagnosis
Disclosure: Eli Lilly and Co., 2; Kyowa Kirin Disclosure: Nothing to Disclose
Pharmaceutical Research, Inc., 2; Roche, 2
Burke, Sarah, DO
5T065 ACR: After R01…Now What? Success 3S048 ACR: Knowledge Bowl Preliminary
Tips for Early Established Investigators Round
Disclosure: Eli Lilly and Co., 2; Kyowa Kirin Disclosure: Nothing to Disclose
Pharmaceutical Research, Inc., 2; Roche, 2
4M038 ACR: Knowledge Bowl Final Round
Branch, David, MD Disclosure: Nothing to Disclose
5T053 ACR: Antiphospholipid Antibody
Syndrome: The Scary Stuff Burma, Molly, ARNP
Disclosure: UCB, Inc., 2 2S007 Pre-Mtg: ACR/ARHP Immunology
Breakthroughs: Impact on Diagnosis and
Brenner, Michael, MD Therapy
5T115 ACR: AMP: Cells in Target Tissue Disclosure: Nothing to Disclose
Using Single-Cell Technological Advances
Disclosure: Roche, 2, 5

2018 Invited Speaker and Moderator Disclosures 7
Burmester, Gerd R. C
3S091 ACR: EULAR: Back to the Future:
Transformative Vision for RA? Caballero-Uribe Sr., Carlo V, MD, Phd (c)
Disclosure: AbbVie Inc., 2; Pfizer, Inc., 2; 4M048 ACR: PANLAR: Highlighting 75 Years
Roche, 2; UCB, Inc., 2 of Contributions to Global Rheumatology
Disclosure: Nothing to Disclose
Burrage, Lindsay, MD, PhD
5T024 ACR: Genetic Mimics of Rheumatic Calabrese, Leonard H., DO
Diseases 4M039 ACR: Rheumatic Immune-Related
Disclosure: Nothing to Disclose Adverse Events From Cancer
Immunotherapy
Busch, Stacey, RN, BSN, MA Disclosure: Bristol-Myers Squibb, 5, 8;
3S036 ARHP: Performance Evaluations: Genentech, Inc., 5, 8
When & How to Discipline or Terminate
Disclosure: Nothing to Disclose Calamia, Kenneth, MD
4M125 MTP: 052 - Behçet's Syndrome
4M002 ACR/ARHP: How to Set Up a Clinical Disclosure: Nothing to Disclose
Trials Center
Disclosure: **Missing Disclosure** Callen, Jeffrey, MD, FACP, MACR
6W015 ACR/ARHP: Dermatology Update:
Buyon, Jill P., MD New Findings on Rheumatic Skin Disease
3S113 ACR: Curbside Consults Across the Lifespan
Disclosure: Exagen, 2 Disclosure: Nothing to Disclose
4M022 ACR: Lupus Nephritis: Immune Cell Caplan, Arnold, PhD
Networks and Pathogenesis 6W013 ACR: Stem Cell Therapy in
Disclosure: Nothing to Disclose Autoimmunity: A Critical Appraisal of the
Science
5T115 ACR: AMP: Cells in Target Tissue Disclosure: Nothing to Disclose
Using Single-Cell Technological Advances
Disclosure: Nothing to Disclose 3S005 MTP: 002 - Axial
Spondyloarthritis/Ankylosing Spondylitis
Bykerk, Vivian P., MD Disclosure: Nothing to Disclose
3S017 ACR: RA: Beyond Treat to Target
Disclosure: Amgen Inc., 2; BMS, 2 4M008 MTP: 029 - Axial
Spondyloarthritis/Ankylosing Spondylitis
Byram, Kevin, MD Disclosure: Nothing to Disclose
3S015 ACR: Neglected Vasculitis
Disclosure: Nothing to Disclose Cappelli, Laura C.
4M039 ACR: Rheumatic Immune-Related

Adverse Events From Cancer
Immunotherapy

Disclosure: Bristol-Myers Squibb, 2;
Regeneron/Sanofi Genzyme, 5
2018 Invited Speaker and Moderator Disclosures 8
Carandang, Kristine, PhD, OTR/L Chandran, Vinod, MD, MBBS, DM, PhD
5T043 ARHP: Don’t Overextend: 5T046 ACR Abstract: Plenary Session III
Hypermobility Rehab Approaches (2785–2790)
Disclosure: Nothing to Disclose Disclosure: AbbVie Inc., 2; AbbVie Inc.,
amgen, celgene, eli lilly, Janssen, Novartis,
Carrizales-Luna, Juan Pablo Pfizer and UCB, 5; Eli Lilly and Co., 9
3S048 ACR: Knowledge Bowl Preliminary
Round Chang, Anthony, MD
Disclosure: Nothing to Disclose 3S074 Workshop: 206 - Renal
Histopathology in SLE & Vasculitis
4M038 ACR: Knowledge Bowl Final Round Disclosure: Alexion Pharmaceuticals, 5, 8;
Disclosure: Nothing to Disclose Elsevier, 7
Carroll, Michael, PhD 4M092 ACR: Osteoporosis: Bone-Breaking
4M021 ACR: Inflammation & Mental Health: News
Lupus & Beyond Disclosure: Nothing to Disclose
Disclosure: **Missing Disclosure**
Chatham, Winn, MD
5T094 ACR: State-of-the-Art Scientific 3S125 MTP: 024 - Neuropsychiatric Lupus
Discovery in Neuroinflammation Disclosure: Nothing to Disclose
Disclosure: Pfizer INC, 2
Chen, Lan, MD, PhD
Chakravarty, Eliza, MD, MS 3S030 Workshop: 203 - Synovial Fluid
3S054 MTP: 015 - Difficult to Treat SLE Analysis & Crystal Identification
Disclosure: Nothing to Disclose Disclosure: Nothing to Disclose
4M054 MTP: 042 - Difficult to Treat SLE 4M058 ACR: Celiac Disease & Its
Disclosure: Nothing to Disclose Relationship With Autoimmune Diseases
5T096 ACR: Reproductive Health in Disclosure: Nothing to Disclose
Rheumatology Patients: New ACR Clinical
Guideline 5T097 ACR/ARHP: Fibromyalgia in RA,
Disclosure: Nothing to Disclose Spondyloarthritis or Sjögren’s Syndrome
Patients
Chambers, Christina D, PhD, MPH Disclosure: Nothing to Disclose
5T096 ACR: Reproductive Health in
Rheumatology Patients: New ACR Clinical 3S020 ACR: Sensing the Enemy Within:
Guideline Cytosolic Nucleic Acid Receptors
Disclosure: AAAAI, 2; Amgen Inc., 2; Birth Disclosure: Nothing to Disclose
Defects Research, 9; Celgene Corporation, 2;
Genzyme Sanofi-Aventis), 2; Cho, Janet, Pharm.D., CDE, BCGP
GlaxoSmithKline, 2; Hoffman La Roche, 2; 4M115 ACR/ARHP: Integrating Pharmacists
Janssen, 2; Pfizer, 2; Sanofi, 2; Sanofi- Into the Workforce
Aventis, 2; Takeda, 2; UCB Pharma Inc., 2 Disclosure: Nothing to Disclose
2018 Invited Speaker and Moderator Disclosures 9
Chong, Benjamin F., MD, MSCS Clauw, Daniel J., MD
4M123 MTP: 050 - Lupus in the Skin: Myths 3S118 ACR/ARHP: The Pain Chronicles:
and Realities National Strategies to Address & Manage
Disclosure: Biogen Incorporated, 2; Celgene Pain
Corporation, 5; Daavlin Incorporated, 2; Disclosure: Abbott Pharmaceutical, 5;
Pfizer Incorporated, 9 Aptinyx, 2, 5; Astellas Pharmaceutical, 5;
Cerephex, 2, 5; Daiichi Sankyo, 5; Pfizer Inc,
Christenson, Mary E., PhD, PT 2, 5; Pierre Fabre, 8; Samumed, 5;
5T043 ARHP: Don’t Overextend: Theravance, 5; Tonix, 5; Williams Connolly
Hypermobility Rehab Approaches LLP, 5; Zynerba, 5
Disclosure: Nothing to Disclose
4M015 MTP: 036 - Fibromyalgia 2018:
Christopher-Stine, Lisa, M.D., M.P.H. Update on Management
3S113 ACR: Curbside Consults Disclosure: Abbott Pharmaceutical, 5;
Disclosure: Inova Diagnostics, 7 Aptinyx, 2, 5; Astellas Pharmaceutical, 5;
Cerephex, 2, 5; Daiichi Sankyo, 5; Pfizer Inc,
Chung, Antanya, CPC, CPC-I, CRHC, CCS-P 2, 5; Pierre Fabre, 8; Samumed, 5;
1F002 Pre-Mtg: ACR Coding: Unlock the Theravance, 5; Tonix, 5; Williams Connolly
Mysteries of Advanced Coding for LLP, 5; Zynerba, 5
Rheumatology
Disclosure: Nothing to Disclose Clayburne, Gilda M., MLT
3S030 Workshop: 203 - Synovial Fluid
3S020 ACR: Sensing the Enemy Within: Analysis & Crystal Identification
Cytosolic Nucleic Acid Receptors Disclosure: Nothing to Disclose
Disclosure: Nothing to Disclose
Cleveland, Becki, PhD
4M001 ACR: CPC: Under the Microscope: 3S116 ACR/ARHP: Innovative Statistics:
The Evolution of a Diagnosis Joint Modeling of Time-to-Event &
Disclosure: Nothing to Disclose Longitudinal Data
Disclosure: Nothing to Disclose
3S044 ACR: 2018 CARE: MOC Session 1 of 3:
Vasculitis 5T027 ACR/ARHP: Answering Clinically
Disclosure: Nothing to Disclose Relevant Questions Using Large Datasets
Disclosure: Nothing to Disclose
Clark, Alex
2S005 Pre-Mtg: ACR BRC: Epigenetics in Clough, Brent
Immune-Mediated Disease: Day 2 of 2 5T031 ACR: PBMs & Providers: Superior
Disclosure: Nothing to Disclose Patient Care Through Transparency
Disclosure: Trio Health, 1
4M022 ACR: Lupus Nephritis: Immune Cell
Networks and Pathogenesis
Disclosure:

2018 Invited Speaker and Moderator Disclosures 10